Improving availability of patient-friendly tuberculosis preventive therapy
Global partners working to tackle the tuberculosis (TB) epidemic have announced the latest in a package of measures to increase supply security and availability of a short-course TB preventive therapy
High risk of Tuberculosis in people living with HIV
The Lancet Global Health journal reports the findings of a study of a host blood test that can find those at high risk of tuberculosis in people living with HIV.
New patient-friendly tuberculosis preventive therapy to be rolled out in five high-burden TB countries at affordable price
• Fixed-dose combination treatments reduce the pill burden from nine to three pills a week for adults and prevent TB in those at highest risk of developing the disease
The Aurum Institute and IAS to Present the Inaugural Gita Ramjee Prize at HIVR4P // Virtual
Johannesburg, 25 January 2021- The Aurum Institute, in collaboration with the International AIDS Society (IAS), will present the inaugural Gita Ramjee Prize at the upcoming HIV Research for Prevention Conference
The Aurum Institute awarded grant by NIH for Clinical Trials Unit
JOHANNESBURG, 1 DECEMBER 2020 - The Aurum Institute has been awarded a seven-year grant by the National Institutes of Health (NIH) for a Clinical Trials Unit (CTU) to drive the
Nedbank steps up national response to COVID-19 pandemic, joins forces with The Aurum Institute to scale up COVID-19 testing
To support efforts in curbing the spread of Coronavirus (COVID-19) in South Africa, Nedbank will donate R1 million to healthcare organisation The Aurum Institute to scale up mobile testing of
